Prothena Corp Public (PRTA) EBIT (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly EBIT came in at $30.0 million in Q1 2026, up 145.8% year-on-year from $12.2 million in Q1 2025, and up 224.1% quarter-over-quarter from -$24.2 million in Q4 2025.
Prothena Corp Public (PRTA) EBIT (2012 - 2026) Analysis & Trends
Prothena Corp Public's EBIT history runs 15 years deep, the most recent figure standing at $30.0 million for Q1 2026.
- On a quarterly basis, EBIT rose 145.8% year-over-year to $30.0 million in Q1 2026; TTM through Mar 2026 was -$119.0 million, a 14.13% increase from a year earlier, with the FY2025 full-year figure at -$214.6 million, down 38.87% from the prior year.
- EBIT improved to $30.0 million in Q1 2026 per PRTA's latest filing, from -$24.2 million in the prior quarter.
- Across five years, EBIT topped out at $58.4 million in Q2 2024 and bottomed at -$84.6 million in Q2 2025.
- The 5-year median for EBIT is -$50.3 million (2022), against an average of -$38.9 million.
- Across the five-year window, EBIT sank 108948.61% in 2023 and jumped 187.78% in 2024, its largest moves.
- Year by year, EBIT stood at -$72000.0 in 2022, then sank by 108948.61% to -$78.5 million in 2023, then advanced by 17.34% to -$64.9 million in 2024, then jumped by 62.71% to -$24.2 million in 2025, then jumped by 224.1% to $30.0 million in 2026.
- Per Business Quant, the three latest PRTA EBIT figures stand at $30.0 million (Q1 2026), -$24.2 million (Q4 2025), and -$40.2 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | 30.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.04 Mn |
| Dec 31, 2025 | -24.20 Mn |
| Sep 30, 2025 | -40.24 Mn |
| Jun 30, 2025 | -84.62 Mn |
| Mar 31, 2025 | -65.58 Mn |
| Dec 31, 2024 | -64.90 Mn |
| Sep 30, 2024 | -66.51 Mn |
| Jun 30, 2024 | 58.38 Mn |
| Mar 31, 2024 | -81.53 Mn |
| Dec 31, 2023 | -78.52 Mn |
| Sep 30, 2023 | 10.31 Mn |
| Jun 30, 2023 | -66.50 Mn |
| Mar 31, 2023 | -56.33 Mn |
| Dec 31, 2022 | -72,000.00 |
| Sep 30, 2022 | -50.33 Mn |
| Jun 30, 2022 | -43.21 Mn |
| Mar 31, 2022 | -37.94 Mn |
| Dec 31, 2021 | -33.09 Mn |
| Sep 30, 2021 | 109.23 Mn |
| Jun 30, 2021 | 27.95 Mn |